Cellyan Biotechnology (HKPD)
Cross-border OTC pharmaceutical fulfillment and distribution for Mainland Chinese e-commerce.
Something off on this page? Send us feedback.
Provides regulated cross-border supply-chain services and OTC pharmaceutical procurement and distribution for business customers serving Mainland Chinese e-commerce demand. Hong Kong subsidiaries earn service fees for fulfillment and sell products to merchants and pharmaceutical distributors under a Cayman holding company.
Provides regulated cross-border supply-chain services and procurement and distribution of overseas OTC pharmaceuticals for merchants and logistics partners serving Mainland Chinese e-commerce customers. Its Hong Kong operations review products, handle Department of Health registrations and import/export documentation, warehouse and package goods, coordinate customs clearance, and arrange delivery handoffs.
Earns service fees for order processing, warehousing, customs clearance and value-added work; separately sources OTC products, arranges their import, and sells them to platform merchants and pharmaceutical distributors. A proprietary ERP integrates order processing with warehouse-management software and supports batch packing.
Operations are concentrated in Hong Kong, with demand tied mainly to Mainland Chinese cross-border e-commerce. Licenses, eligible-product registration, suppliers, outsourced customs and delivery services, contracted labor, and relationships with logistics partners and merchants underpin execution.
Company facts
No analyst consensus on record.
Not reported.
Balance sheet, Mar 31, 2026Cash & short-term investments $221.8K · Total debt $1.3M · Total assets $12.8M · Shareholders' equity $9.6M
- Revenue
- $6.3M
- Operating income
- −$1.2M
- Net income
- −$1.3M
No dividends on record.
| Institutions | 2.23% | 245.3K shares | |
|---|---|---|---|
| 6 holders · as of Jun 30, 2026 | |||
| Insiders | 57.05% | 6.26M shares | |
| 1 holder · as of Jun 3, 2025 | |||
| Strategic holders | 11.25% | 1.24M shares | |
| 2 holders · as of Jun 5, 2025 | |||
| Other | 29.47% | 3.23M shares | |
| remainder | |||
10.98M company shares as of Sep 5, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
Lap Sun Wong1Insiderdirector | 57.05% | 6.24M · 18,468 | filed Jun 3, 2025 |
Atlantic Health Century International GroupStrategic | 5.63% | 617,850 | filed Jun 5, 2025 |
Pacific Health Century International GroupStrategic | 5.63% | 617,850 | filed Jun 5, 2025 |
Stonex Group Inc.Institution | 0.93% | 102,310 | as of Jun 30, 2026 |
Jane Street Group, LLCInstitution | 0.45% | 49,087 | as of Jun 30, 2026 |
- Lap Sun Wong's transaction reports restate only vehicles that traded; the 2025 ownership statement (6.24M) is used instead.
Insider tradesForm 4
Nothing filed in the last 12 months.
Not reported.